163 related articles for article (PubMed ID: 32596309)
1. PLP2 Expression as a Prognostic and Therapeutic Indicator in High-Risk Multiple Myeloma.
Bai H; Zhu Y; Xu P; Chen B
Biomed Res Int; 2020; 2020():4286101. PubMed ID: 32596309
[TBL] [Abstract][Full Text] [Related]
2. Proteolipid Protein 2 Overexpression Indicates Aggressive Tumor Behavior and Adverse Prognosis in Human Gliomas.
Chen YH; Hueng DY; Tsai WC
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373180
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of proteolipid protein 2 increases ER stress-induced apoptosis and autophagy in glioblastoma.
Feng Z; Zhou W; Wang J; Qi Q; Han M; Kong Y; Hu Y; Zhang Y; Chen A; Huang B; Chen A; Zhang D; Li W; Zhang Q; Bjerkvig R; Wang J; Thorsen F; Li X
J Cell Mol Med; 2020 Mar; 24(5):2847-2856. PubMed ID: 31778016
[TBL] [Abstract][Full Text] [Related]
4. MiR-765 functions as a tumour suppressor and eliminates lipids in clear cell renal cell carcinoma by downregulating PLP2.
Xiao W; Wang C; Chen K; Wang T; Xing J; Zhang X; Wang X
EBioMedicine; 2020 Jan; 51():102622. PubMed ID: 31901870
[TBL] [Abstract][Full Text] [Related]
5. MiR-422a weakened breast cancer stem cells properties by targeting PLP2.
Zou Y; Chen Y; Yao S; Deng G; Liu D; Yuan X; Liu S; Rao J; Xiong H; Yuan X; Yu S; Zhu F; Wang Y; Xiong H
Cancer Biol Ther; 2018 May; 19(5):436-444. PubMed ID: 29509055
[TBL] [Abstract][Full Text] [Related]
6. RGS1 expression is associated with poor prognosis in multiple myeloma.
Roh J; Shin SJ; Lee AN; Yoon DH; Suh C; Park CJ; Huh J; Park CS
J Clin Pathol; 2017 Mar; 70(3):202-207. PubMed ID: 27445341
[TBL] [Abstract][Full Text] [Related]
7. Low Expression of A3C and PLP2 Indicating a Favorable Prognosis in Human Gliomas.
Jin JS; Tsai YL; Chang YC; Tsai WC
Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):71-79. PubMed ID: 37715423
[TBL] [Abstract][Full Text] [Related]
8. PLP2-derived peptide Rb4 triggers PARP-1-mediated necrotic death in murine melanoma cells.
Maia VSC; Berzaghi R; Arruda DC; Machado FC; Loureiro LL; Melo PMS; Morais AS; Budu A; Travassos LR
Sci Rep; 2022 Feb; 12(1):2890. PubMed ID: 35190586
[TBL] [Abstract][Full Text] [Related]
9. Effect of transfection with PLP2 antisense oligonucleotides on gene expression of cadmium-treated MDA-MB231 breast cancer cells.
Longo A; Librizzi M; Luparello C
Anal Bioanal Chem; 2013 Feb; 405(6):1893-901. PubMed ID: 22729357
[TBL] [Abstract][Full Text] [Related]
10. Adverse prognostic impact of bone marrow microvessel density in multiple myeloma.
Lee N; Lee H; Moon SY; Sohn JY; Hwang SM; Yoon OJ; Youn HS; Eom HS; Kong SY
Ann Lab Med; 2015 Nov; 35(6):563-9. PubMed ID: 26354343
[TBL] [Abstract][Full Text] [Related]
11. The long noncoding RNA ZFAS1 promotes the progression of glioma by regulating the miR-150-5p/PLP2 axis.
Li X; Luo Y; Liu L; Cui S; Chen W; Zeng A; Shi Y; Luo L
J Cell Physiol; 2020 Mar; 235(3):2937-2946. PubMed ID: 31535380
[TBL] [Abstract][Full Text] [Related]
12. The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors.
Paul B; Zhao Y; Loitsch G; Feinberg D; Mathews P; Barak I; Dupuis M; Li Z; Rein L; Wang E; Kang Y
Cancer Med; 2020 Aug; 9(16):5869-5880. PubMed ID: 32628819
[TBL] [Abstract][Full Text] [Related]
13. CD56 expression in multiple myeloma: Correlation with poor prognostic markers but no effect on outcome.
Koumpis E; Tassi I; Malea T; Papathanasiou K; Papakonstantinou I; Serpanou A; Tsolas E; Kapsali E; Vassilakopoulos TP; Papoudou-Bai A; Hatzimichael E
Pathol Res Pract; 2021 Sep; 225():153567. PubMed ID: 34352440
[TBL] [Abstract][Full Text] [Related]
14. miR-664 negatively regulates PLP2 and promotes cell proliferation and invasion in T-cell acute lymphoblastic leukaemia.
Zhu H; Miao MH; Ji XQ; Xue J; Shao XJ
Biochem Biophys Res Commun; 2015 Apr; 459(2):340-345. PubMed ID: 25735976
[TBL] [Abstract][Full Text] [Related]
15. Identification of PLP2 and RAB5C as novel TPD52 binding partners through yeast two-hybrid screening.
Shahheydari H; Frost S; Smith BJ; Groblewski GE; Chen Y; Byrne JA
Mol Biol Rep; 2014 Jul; 41(7):4565-72. PubMed ID: 24604726
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of cyclin D1 and p53 in multiple myeloma: relationship to proliferative activity and prognostic significance.
Markovic O; Marisavljevic D; Cemerikic V; Suvajdzic N; Milic N; Colovic M
Med Oncol; 2004; 21(1):73-80. PubMed ID: 15034217
[TBL] [Abstract][Full Text] [Related]
17. Haploid genetic screens identify an essential role for PLP2 in the downregulation of novel plasma membrane targets by viral E3 ubiquitin ligases.
Timms RT; Duncan LM; Tchasovnikarova IA; Antrobus R; Smith DL; Dougan G; Weekes MP; Lehner PJ
PLoS Pathog; 2013; 9(11):e1003772. PubMed ID: 24278019
[TBL] [Abstract][Full Text] [Related]
18. Ki-67 proliferation index: correlation with prognostic parameters and outcome in multiple myeloma.
Alexandrakis MG; Passam FH; Kyriakou DS; Dambaki K; Niniraki M; Stathopoulos E
Am J Clin Oncol; 2004 Feb; 27(1):8-13. PubMed ID: 14758126
[TBL] [Abstract][Full Text] [Related]
19. Expression of multiple myeloma associated markers in bone marrow spicules using a novel immunohistochemical technique.
Santra M; Shaughnessy JD; Bellamy WT
Biotech Histochem; 2011 Apr; 86(2):119-23. PubMed ID: 20438295
[TBL] [Abstract][Full Text] [Related]
20. High Expression of Phosphorylated Extracellular Signal-Regulated Kinase (ERK1/2) is Associated with Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma.
Fan L; Hong J; Huang H; Fu D; Wu S; Wang Q; Ye Y; Liu Y
Med Sci Monit; 2017 May; 23():2636-2643. PubMed ID: 28557972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
